{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:26:04Z","timestamp":1786947964814,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01899-2","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:06:42Z","timestamp":1786946802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-driven arginine depletion induces T-cell metabolism reprogramming to suppress atherosclerosis in colorectal cancer"],"prefix":"10.1038","author":[{"given":"Wen-jun","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-zhang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-cong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-xiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"1899_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524\u201333.","journal-title":"Nature"},{"key":"1899_CR2","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1161\/ATVBAHA.124.319396","volume":"44","author":"K Kawai","year":"2024","unstructured":"Kawai K, Kawakami R, Finn AV, Virmani R. Differences in stable and unstable atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2024;44:1474\u201384.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1899_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02460-1","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Fan J, Kong D, Sun Y, Zhang Q, Xiang R, et al. Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy. Mol Cancer. 2025;24:249.","journal-title":"Mol Cancer"},{"key":"1899_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/eurheartj\/ehae047","volume":"45","author":"P Ameri","year":"2024","unstructured":"Ameri P, Bertero E, Lombardi M, Porto I, Canepa M, Nohria A, et al. Ischaemic heart disease in patients with cancer. Eur Heart J. 2024;45:1209\u201323.","journal-title":"Eur Heart J"},{"key":"1899_CR5","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/ejhf.1539","volume":"21","author":"RA de Boer","year":"2019","unstructured":"de Boer RA, Meijers WC, van der Meer P, van Veldhuisen DJ. Cancer and heart disease: associations and relations. Eur J Heart Fail. 2019;21:1515\u201325.","journal-title":"Eur J Heart Fail"},{"key":"1899_CR6","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","volume":"25","author":"DM Fernandez","year":"2019","unstructured":"Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir ED, Amadori L, et al. Single-cell immune landscape of human atherosclerotic plaques. Nat Med. 2019;25:1576\u201388.","journal-title":"Nat Med"},{"key":"1899_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02193-7","volume":"23","author":"M Gan","year":"2024","unstructured":"Gan M, Liu N, Li W, Chen M, Bai Z, Liu D, et al. Metabolic targeting of regulatory T cells in oral squamous cell carcinoma: new horizons in immunotherapy. Mol Cancer. 2024;23:273.","journal-title":"Mol Cancer"},{"key":"1899_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.cmet.2022.02.003","volume":"34","author":"SH Moller","year":"2022","unstructured":"Moller SH, Hsueh PC, Yu YR, Zhang L, Ho PC. Metabolic programs tailor T cell immunity in viral infection, cancer, and aging. Cell Metab. 2022;34:378\u201395.","journal-title":"Cell Metab"},{"key":"1899_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","volume":"17","author":"R Saigusa","year":"2020","unstructured":"Saigusa R, Winkels H, Ley K. T cell subsets and functions in atherosclerosis. Nat Rev Cardiol. 2020;17:387\u2013401.","journal-title":"Nat Rev Cardiol"},{"key":"1899_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","volume":"21","author":"S Ma","year":"2024","unstructured":"Ma S, Ming Y, Wu J, Cui G. Cellular metabolism regulates the differentiation and function of T-cell subsets. Cell Mol Immunol. 2024;21:419\u201335.","journal-title":"Cell Mol Immunol"},{"key":"1899_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","volume":"585","author":"Y Bian","year":"2020","unstructured":"Bian Y, Li W, Kremer DM, Sajjakulnukit P, Li S, Crespo J, et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature. 2020;585:277\u201382.","journal-title":"Nature"},{"key":"1899_CR12","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s44318-025-00379-3","volume":"44","author":"TS Fung","year":"2025","unstructured":"Fung TS, Ryu KW, Thompson CB. Arginine: at the crossroads of nitrogen metabolism. EMBO J. 2025;44:1275\u201393.","journal-title":"EMBO J"},{"key":"1899_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12933-024-02490-x","volume":"23","author":"A Fiordelisi","year":"2024","unstructured":"Fiordelisi A, Cerasuolo FA, Avvisato R, Buonaiuto A, Maisto M, Bianco A, et al. L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy. Cardiovasc Diabetol. 2024;23:450.","journal-title":"Cardiovasc Diabetol"},{"key":"1899_CR14","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","volume":"167","author":"R Geiger","year":"2016","unstructured":"Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T, et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167:829\u201342.e13.","journal-title":"Cell"},{"key":"1899_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307256","volume":"11","author":"X Cao","year":"2024","unstructured":"Cao X, Wu VWY, Han Y, Hong H, Wu Y, Kong APS, et al. Role of argininosuccinate synthase 1-dependent L-arginine biosynthesis in the protective effect of endothelial sirtuin 3 against atherosclerosis. Adv Sci (Weinh). 2024;11:e2307256.","journal-title":"Adv Sci (Weinh)"},{"key":"1899_CR16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s10620-016-4041-5","volume":"61","author":"Y Yamaji","year":"2016","unstructured":"Yamaji Y, Yasunaga H, Hirata Y, Yamada A, Yoshida S, Horiguchi H, et al. Association between colorectal cancer and atherosclerotic diseases: a study using a national inpatient database in Japan. Dig Dis Sci. 2016;61:1677\u201385.","journal-title":"Dig Dis Sci"},{"key":"1899_CR17","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1161\/CIRCRESAHA.118.313413","volume":"124","author":"Y Chang","year":"2019","unstructured":"Chang Y, Kim JH, Noh JW, Cho YS, Park HJ, Joo KJ, et al. Prostate-specific antigen within the reference range, subclinical coronary atherosclerosis, and cardiovascular mortality. Circ Res. 2019;124:1492\u2013504.","journal-title":"Circ Res"},{"key":"1899_CR18","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.prp.2016.07.019","volume":"212","author":"A Jirasek","year":"2016","unstructured":"Jirasek A, Knief J, Deng M, Reddemann K, Thorns C. Evaluation of general and coronary atherosclerosis and malignant disease demonstrates inverse correlations for specific cancer types as well as cancer in general. Pathol Res Pract. 2016;212:988\u201394.","journal-title":"Pathol Res Pract."},{"key":"1899_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.12.002","volume":"21","author":"IN Agmon","year":"2026","unstructured":"Agmon IN, Zhan LJ, Ho G, Foroutan F, Power C, Bezjak A, et al. The risk of cardiovascular adverse outcomes in patients with thymoma or thymic carcinoma receiving cancer therapy. J Thorac Oncol. 2026;21:103532.","journal-title":"J Thorac Oncol"},{"key":"1899_CR20","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Deng L, Bluethmann SM, Zhou S, Trifiletti DM, Jiang C, et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur Heart J. 2019;40:3889\u201397.","journal-title":"Eur Heart J"},{"key":"1899_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12933-024-02370-4","volume":"23","author":"FF You","year":"2024","unstructured":"You FF, Gao J, Gao YN, Li ZH, Shen D, Zhong WF, et al. Association between atherogenic index of plasma and all-cause mortality and specific-mortality: a nationwide population\u2011based cohort study. Cardiovasc Diabetol. 2024;23:276.","journal-title":"Cardiovasc Diabetol"},{"key":"1899_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51:606.","journal-title":"Am J Cardiol"},{"key":"1899_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.021038","volume":"10","author":"I Goncalves","year":"2021","unstructured":"Goncalves I, Sun J, Tengryd C, Nitulescu M, Persson AF, Nilsson J, et al. Plaque vulnerability index predicts cardiovascular events: a histological study of an endarterectomy cohort. J Am Heart Assoc. 2021;10:e021038.","journal-title":"J Am Heart Assoc"},{"key":"1899_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41569-023-00957-0","volume":"21","author":"GRY De Meyer","year":"2024","unstructured":"De Meyer GRY, Zurek M, Puylaert P, Martinet W. Programmed death of macrophages in atherosclerosis: mechanisms and therapeutic targets. Nat Rev Cardiol. 2024;21:312\u201325.","journal-title":"Nat Rev Cardiol"},{"key":"1899_CR25","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1161\/CIRCRESAHA.122.320263","volume":"130","author":"A Gistera","year":"2022","unstructured":"Gistera A, Ketelhuth DFJ, Malin SG, Hansson GK. Animal models of atherosclerosis-supportive notes and tricks of the trade. Circ Res. 2022;130:1869\u201387.","journal-title":"Circ Res"},{"key":"1899_CR26","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41416-023-02392-x","volume":"129","author":"EM Thomas","year":"2023","unstructured":"Thomas EM, Wright JA, Blake SJ, Page AJ, Worthley DL, Woods SL. Advancing translational research for colorectal immuno-oncology. Br J Cancer. 2023;129:1442\u201350.","journal-title":"Br J Cancer"},{"key":"1899_CR27","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/cvr\/cvae154","volume":"120","author":"H Horstmann","year":"2024","unstructured":"Horstmann H, Michel NA, Sheng X, Hansen S, Lindau A, Pfeil K, et al. Cross-species single-cell RNA sequencing reveals divergent phenotypes and activation states of adaptive immunity in human carotid and experimental murine atherosclerosis. Cardiovasc Res. 2024;120:1713\u201326.","journal-title":"Cardiovasc Res"},{"key":"1899_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"1899_CR29","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.107.729125","volume":"117","author":"A Zernecke","year":"2008","unstructured":"Zernecke A, Bernhagen J, Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation. 2008;117:1594\u2013602.","journal-title":"Circulation"},{"key":"1899_CR30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"A Yurdagul Jr","year":"2020","unstructured":"Yurdagul A Jr, Subramanian M, Wang X, Crown SB, Ilkayeva OR, Darville L, et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 2020;31:518\u201333.e10.","journal-title":"Cell Metab."},{"key":"1899_CR31","doi-asserted-by":"publisher","first-page":"e0126855","DOI":"10.1371\/journal.pone.0126855","volume":"10","author":"M Li","year":"2015","unstructured":"Li M, Cima MJ, Milner DA Jr. If it\u2019s not one thing, it\u2019s another: an inverse relationship of malignancy and atherosclerotic disease. PLoS One. 2015;10:e0126855.","journal-title":"PLoS One"},{"key":"1899_CR32","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1093\/eurjpc\/zwad256","volume":"30","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wei Z, Zhang Y, Zhang Q, Chen Z, Tse G, et al. Association of Life\u2019s Essential 8 with incident atherosclerotic cardiovascular disease in cancer patients: the Kailuan prospective cohort study. Eur J Prev Cardiol. 2023;30:e78\u201380.","journal-title":"Eur J Prev Cardiol"},{"key":"1899_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11764-023-01379-0","volume":"18","author":"EJ Polter","year":"2024","unstructured":"Polter EJ, Blaes A, Wolfson J, Lutsey PL, Florido R, Joshu CE, et al. Performance of the pooled cohort equations in cancer survivors: the Atherosclerosis Risk in Communities study. J Cancer Surviv. 2024;18:124\u201334.","journal-title":"J Cancer Surviv"},{"key":"1899_CR34","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/jnci\/djaf122","volume":"117","author":"Q Liu","year":"2025","unstructured":"Liu Q, Wang Q, Wang K, Han H, Wang M, Wang J, et al. Risk of atherosclerotic cardiovascular disease after cancer diagnosis: findings from 3 prospective cohort studies. J Natl Cancer Inst. 2025;117:1707\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"1899_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jacc.2022.04.042","volume":"80","author":"R Florido","year":"2022","unstructured":"Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, et al. Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2022;80:22\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"1899_CR36","doi-asserted-by":"publisher","first-page":"994","DOI":"10.5551\/jat.RV17027","volume":"25","author":"M Mukai","year":"2018","unstructured":"Mukai M, Komori K, Oka T. Mechanism and management of cancer chemotherapy-induced atherosclerosis. J Atheroscler Thromb. 2018;25:994\u20131002.","journal-title":"J Atheroscler Thromb"},{"key":"1899_CR37","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ccell.2025.03.015","volume":"43","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Zhou Z, Du X, Lin X, Liang ZM, Chen S, et al. Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion. Cancer Cell. 2025;43:1045\u201360.e7.","journal-title":"Cancer Cell"},{"key":"1899_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113995","volume":"43","author":"Z Zou","year":"2024","unstructured":"Zou Z, Cheng Q, Zhou J, Guo C, Hadjinicolaou AV, Salio M, et al. ATF4-SLC7A11-GSH axis mediates the acquisition of immunosuppressive properties by activated CD4+ T cells in low arginine condition. Cell Rep. 2024;43:113995.","journal-title":"Cell Rep"},{"key":"1899_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04604-7","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang Y, Wang Z, Li X, Lv J, Zhong R, Gao S, et al. Profiling the metabolic disorder and detection of colorectal cancer based on targeted amino acids metabolomics. J Transl Med. 2023;21:824.","journal-title":"J Transl Med"},{"key":"1899_CR40","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/ATVBAHA.118.311572","volume":"39","author":"K Nitz","year":"2019","unstructured":"Nitz K, Lacy M, Atzler D. Amino acids and their metabolism in atherosclerosis. Arterioscler Thromb Vasc Biol. 2019;39:319\u201330.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1899_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0021-9150(98)00145-2","volume":"141","author":"RH Boger","year":"1998","unstructured":"Boger RH, Bode-Boger SM, Phivthong-ngam L, Brandes RP, Schwedhelm E, Mugge A, et al. Dietary L-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis. 1998;141:31\u201343.","journal-title":"Atherosclerosis"},{"key":"1899_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCRESAHA.107.169573","volume":"102","author":"S Ryoo","year":"2008","unstructured":"Ryoo S, Gupta G, Benjo A, Lim HK, Camara A, Sikka G, et al. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res. 2008;102:923\u201332.","journal-title":"Circ Res"},{"key":"1899_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3945\/ajcn.2008.26544","volume":"89","author":"Y Bai","year":"2009","unstructured":"Bai Y, Sun L, Yang T, Sun K, Chen J, Hui R. Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2009;89:77\u201384.","journal-title":"Am J Clin Nutr"},{"key":"1899_CR44","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jama.295.1.58","volume":"295","author":"SP Schulman","year":"2006","unstructured":"Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, et al. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006;295:58\u201364.","journal-title":"JAMA"},{"key":"1899_CR45","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/CIRCULATIONAHA.106.683656","volume":"116","author":"AM Wilson","year":"2007","unstructured":"Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP. L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation. 2007;116:188\u201395.","journal-title":"Circulation"},{"key":"1899_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1161\/01.ATV.0000040223.74255.5A","volume":"23","author":"J Chen","year":"2003","unstructured":"Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE\/inducible nitric oxide synthase double-knockout mice. Arterioscler Thromb Vasc Biol. 2003;23:97\u2013103.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"1899_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41401-020-0436-0","volume":"42","author":"LC Ou","year":"2021","unstructured":"Ou LC, Zhong S, Ou JS, Tian JW. Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis. Acta Pharmacol Sin. 2021;42:10\u20137.","journal-title":"Acta Pharmacol Sin"},{"key":"1899_CR48","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/CIRCULATIONAHA.125.073987","volume":"153","author":"RD Schwab","year":"2026","unstructured":"Schwab RD, Degaramo D, Hong SJ, Bi X, Faruqi A, Aguilar W, et al. Chimeric antigen receptor regulatory T cells targeted against oxidized low-density lipoprotein reduce atherosclerotic plaque development. Circulation. 2026;153:319\u201337.","journal-title":"Circulation"},{"key":"1899_CR49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nbt.4195","volume":"36","author":"S Rafiq","year":"2018","unstructured":"Rafiq S, Yeku OO, Jackson HJ, Purdon TJ, van Leeuwen DG, Drakes DJ, et al. Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo. Nat Biotechnol. 2018;36:847\u201356.","journal-title":"Nat Biotechnol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01899-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:06:43Z","timestamp":1786946803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01899-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":49,"alternative-id":["1899"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01899-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}